ArticleMolecular therapy. Nucleic acids2025

Targeting a pathogenic cryptic exon that drives HLRCC to induce exon skipping.

Siddhardha S Maligireddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.